Tebapivat Improves Red Cell Deformability and Decreases Sickling in Patients With Sickle Cell Disease: A Phase 1 Trial Substudy
The data that support the findings of this study are available from the corresponding author upon reasonable request. Data S1: ejh70048-sup-0001-Supinfo.docx. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
Authors
- Enrico M. Novelli (ORCID: https://orcid.org/0000-0003-3010-8285)
- Julia Xu (ORCID: https://orcid.org/0000-0003-4147-8388)
- Jesper Petersen (ORCID: https://orcid.org/0000-0001-6116-5114)
- Jens Helby (ORCID: https://orcid.org/0000-0002-1876-8187)
- Andreas Glenthøj (ORCID: https://orcid.org/0000-0003-2082-0738)
- Nelly Kiriza
- Selma Kofoed Bendtsen
- Brian J. Philips
- Manzoor Mohideen
Institutions
- University of Copenhagen (DK)
- University of Pittsburgh (US)
- Copenhagen University Hospital (DK)
Publication Details
- Journal
- European Journal Of Haematology
- Published
- 2025-10-13
- DOI
- https://doi.org/10.1111/ejh.70048
- Citations
- 1
- Primary Topic
- Hemoglobinopathies and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.63